Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2026-06-09 @ 4:20 PM
Study NCT ID:
NCT01767194
Status:
COMPLETED
Last Update Posted:
2022-10-24
First Post:
2013-01-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma
Sponsor:
Organization: